Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

Abstract Background Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better treatment stratification. We investigated the prognostic value of Programmed Death Ligand-1 (PD-L1) in a true population-ba...

Full description

Bibliographic Details
Main Authors: Ann C. Eriksen, Flemming B. Sørensen, Jan Lindebjerg, Henrik Hager, René dePont Christensen, Sanne Kjær-Frifeldt, Torben F. Hansen
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Cancer
Subjects:
Colon cancer stage II
Prognostic markers
Programmed death ligand-1
Online Access:http://link.springer.com/article/10.1186/s12885-019-5345-6

Internet

http://link.springer.com/article/10.1186/s12885-019-5345-6

Similar Items